Thierry Dubuffet

S33084, a Novel, Potent, Selective, and Competitive Antagonist at Dopamine D3-Receptors: I. Receptorial, Electrophysiological and Neurochemical Profile Compared with GR218,231 and L741,626

Mark J. Millan, Alain P. Gobert, Adrian Newman‐Tancredi et al. · Journal of Pharmacology and Experimental Therapeutics · 2000 · 125 citations · Full text

S33084, a Novel, Potent, Selective, and Competitive Antagonist at Dopamine D3-Receptors: II. Functional and Behavioral Profile Compared with GR218,231 and L741,626

Mark J. Millan, Anne Dekeyne, Jean‐Michel Rivet et al. · Journal of Pharmacology and Experimental Therapeutics · 2000 · 120 citations

Novel benzopyrano[3,4-c]pyrrole derivatives as potent and selective dopamine D3 receptor antagonists

Thierry Dubuffet, Adrian Newman‐Tancredi, Didier Cussac et al. · Bioorganic & Medicinal Chemistry Letters · 1999 · 73 citations · Full text

Functional Selectivity, Medicine, Pharmacological Agent +5

S33138 [N-[4-[2-[(3 aS,9 bR)-8-cyano-1,3 a,4,9 b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3 H)-yl)-ethyl]phenylacetamide], A Preferential Dopamine D3 versus D2 Receptor Antagonist and Potential Antipsychotic Agent: I. Receptor-Binding Profile and Functional Actions at G-Protein-Coupled Receptors

Mark J. Millan, Clotilde Mannoury la Cour, Francesca Novi et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 62 citations

S 18886, a New Thromboxane (TP)-Receptor Antagonist Is the Active Isomer of S 18204 in All Species, Except in the Guinea-Pig

Serge Simonet, Jean‐Jacques Descombes, Marie‐Odile Vallez et al. · Advances in experimental medicine and biology · 1997 · 46 citations

Molecular Pharmacology, Active Isomer, S 18204 +8